Not applicableStudy completedNCT03408093What this trial is testingStudy of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1bWho this might be right forMultiple Sclerosis Bayer 120
Very early researchStudy completedNCT05357833What this trial is testingNovel Imaging Markers in SPMSWho this might be right forSecondary Progressive Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis University of Utah 11
Early research (Phase 1)Study completedNCT06360861What this trial is testingEvaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple SclerosisWho this might be right forMultiple SclerosisSecondary-Progressive Multiple SclerosisMesenchymal Stem Cells Tehran University of Medical Sciences 5
Large-scale testing (Phase 3)Looking for participantsNCT07225504What this trial is testingEvaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisWho this might be right forSecondary Progressive Multiple Sclerosis (SPMS) Novartis Pharmaceuticals 1,275
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06961383What this trial is testingStudy of NG01 Cell Therapy in Secondary Progressive Multiple SclerosisWho this might be right forSecondary Progressive Multiple Sclerosis (SPMS) NeuroGenesis Ltd. 45
Not applicableStudy completedNCT04593927What this trial is testingLong Term Special Drug Use-results Surveillance for Mayzent in SPMS PatientsWho this might be right forSecondary Progressive Multiple Sclerosis (SPMS) Novartis Pharmaceuticals 451
Large-scale testing (Phase 3)Ended earlyNCT02430532What this trial is testingBG00012 and Delay of Disability Progression in Secondary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis, Secondary Progressive Biogen 58
Large-scale testing (Phase 3)Study completedNCT03387670What this trial is testingMultiple Sclerosis-Simvastatin Trial 2Who this might be right forSecondary Progressive Multiple Sclerosis (SPMS) University College, London 964
Testing effectiveness (Phase 2)Study completedNCT02308137What this trial is testingDomperidone in Secondary Progressive Multiple Sclerosis (SPMS)Who this might be right forMultiple Sclerosis, Secondary Progressive University of Calgary 64
Not applicableStudy completedNCT04120675What this trial is testingEfficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis Aristotle University Of Thessaloniki 30
Testing effectiveness (Phase 2)UnknownNCT05013463What this trial is testingHydroxychloroquine and Indapamide in SPMSWho this might be right forMultiple Sclerosis, Secondary Progressive University of Calgary 35
Not applicableLooking for participantsNCT05177523What this trial is testingImaging the Interplay Between Axonal Damage and Repair in Multiple SclerosisWho this might be right forMultiple Sclerosis (MS)Relapsing-remitting Multiple Sclerosis (RRMS)Secondary-progressive Multiple Sclerosis (SPMS)+1 more University Hospital, Basel, Switzerland 300
Testing effectiveness (Phase 2)WithdrawnNCT01181089What this trial is testingDose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS)Who this might be right forSecondary Progressive Multiple Sclerosis Biogen
Not applicableStudy completedNCT07168694What this trial is testingA Real-world Study About the Impact of Siponimod Treatment on Secondary Progressive Multiple Sclerosis Patients in RussiaWho this might be right forSecondary Progressive Multiple Sclerosis Novartis Pharmaceuticals 606
Early research (Phase 1)Ended earlyNCT01144351What this trial is testingA Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis Elan Pharmaceuticals 32
Testing effectiveness (Phase 2)Study completedNCT02228213What this trial is testingSafety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple SclerosisWho this might be right forSecondary Progressive Multiple Sclerosis Innate Immunotherapeutics 93
Post-approval studies (Phase 4)UnknownNCT04550455What this trial is testingA Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine TabletsWho this might be right forMultiple Sclerosis Keith Edwards, M.D. 30
Not applicableStudy completedNCT01235455What this trial is testingPortuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectorsWho this might be right forRelapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS) Bayer 10
Early research (Phase 1)Study completedNCT01381354What this trial is testingNutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)Who this might be right forMultiple Sclerosis University of Iowa 38
Early research (Phase 1)Study completedNCT06683612What this trial is testingPET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPFWho this might be right forIdiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more Contineum Therapeutics 16